Your new experience awaits. Try the new design now and help us make it even better

BRIEF RESEARCH REPORT article

Front. Digit. Health

Sec. Health Technology Implementation

Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1570009

This article is part of the Research TopicUnlocking the Potential of Health Data: Interoperability, Security, and Emerging Challenges in AI, LLM, Precision Medicine, and Their Impact on Healthcare and ResearchView all 5 articles

Enhancing Gen3 for Clinical Trial Time Series Analytics and Data Discovery: A Data Commons Framework for NIH Clinical Trials

Provisionally accepted
Meredith  C. B. AdamsMeredith C. B. Adams1*Colin  GriffithColin Griffith2Hunter  AdamsHunter Adams2Stephen  BryantStephen Bryant2Robert  W HurleyRobert W Hurley1Umit  TopalogluUmit Topaloglu1,3
  • 1School of Medicine, Wake Forest University, Winston-Salem, United States
  • 2Krumware LLC, Columbia, SC, United States
  • 3National Institutes of Health (NIH), Bethesda, Maryland, United States

The final, formatted version of the article will be published soon.

This work presents a framework for enhancing Gen3, an open-source data commons platform, with temporal visualization capabilities for clinical trial research. We describe the technical implementation of cloud-native architecture and integrated visualization tools that enable standardized analytics for longitudinal clinical trial data while adhering to FAIR principles. The enhancement includes Kubernetes-based container orchestration, Kibana-based temporal analytics, and automated ETL pipelines for data harmonization. Technical validation demonstrates reliable handling of varied time-based data structures, while maintaining temporal precision and measurement context. The framework's implementation in NIH HEAL Initiative networks studying chronic pain and substance use disorders showcases its utility for real-time monitoring of longitudinal outcomes across multiple trials. This adaptation provides a model for research networks seeking to enhance their data commons capabilities while ensuring findable, accessible, interoperable, and reusable clinical trial data.

Keywords: data commons, Cloud computing, opioid, Chronic Pain, Kubernetes, Gen3, timeseries, Patient Reported Outcomes

Received: 02 Feb 2025; Accepted: 23 Jun 2025.

Copyright: © 2025 Adams, Griffith, Adams, Bryant, Hurley and Topaloglu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Meredith C. B. Adams, School of Medicine, Wake Forest University, Winston-Salem, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.